OTCMKTS:MEOBF

Mesoblast (MEOBF) News Today

$0.35

-0.50 (-58.82%)

(As of 08/4/2023)

Compare

Today's Range: $0.35
▼
$0.35
50-Day Range: $0.35
▼
$1.00
52-Week Range: $0.35
▼
$1.00

Volume: 2,000 shs
Average Volume: 1,950 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Headlines SEC Filings Short Interest

Source

Source	Headline
	Mesoblast Limited (MEOBF) Stock Historical Prices & Data - Yahoo Finance finance.yahoo.com - January 11 at 6:24 PM
	MESO.O - Mesoblast limited (ADR) \| Stock Price & Latest News \| Reuters reuters.com - September 29 at 9:39 PM
	Mesoblast Teva Starts investing.com - September 29 at 4:34 PM
	Mesoblast Limited (MESO) Q4 2022 Earnings Call Transcript seekingalpha.com - September 1 at 11:18 PM
	Mesoblast Limited 2022 Q4 - Results - Earnings Call Presentation seekingalpha.com - September 1 at 11:18 PM
	MindMed Appoints Schond L. Greenway As CFO markets.businessinsider.com - May 25 at 9:37 AM
	Mesoblast (OTC:MEOBF), Short Interest Report benzinga.com - May 25 at 9:37 AM
	Mesoblast (OTC:MEOBF), Earnings Estimates, EPS, and Revenue benzinga.com - May 25 at 9:37 AM
	Mesoblast reports FQ3 results seekingalpha.com - April 29 at 7:22 AM
	Mesoblast Limited (MESO) Q1 2022 Earnings Call Transcript fool.com - March 28 at 10:10 PM
	Why Mesoblast Stock Is Plunging After Q4 Earnings Report? markets.businessinsider.com - August 31 at 12:26 PM
	Loss-Making Mesoblast Limited (ASX:MSB) Expected To Breakeven In The Medium-Term finance.yahoo.com - August 24 at 10:19 PM
	Mesoblast Shares 90-Day Survival Outcomes After Remestemcel-L From COVID-19 ARDS Trial finance.yahoo.com - July 19 at 1:18 PM
	Ninety Day Survival Outcomes in COVID-19 ARDS Trial of Remestemcel-L Presented at ISCT Meeting on Advances in Cell & Gene Therapies for Lung Diseases benzinga.com - July 18 at 9:04 PM
	Mesoblast Presents Respiratory Function Results of COVID-19 ARDS Trial at Pulmonary Disease Conference finance.yahoo.com - July 15 at 11:30 PM
	Mesoblast Updates On Rexlemestrocel-L Program In Chronic Low Back Pain finance.yahoo.com - July 1 at 12:45 PM
	Mesoblast Provides Update on Program for Chronic Low Back Pain Due to Degenerative Disc Disease finance.yahoo.com - June 30 at 8:22 PM
	Is Mesoblast (ASX:MSB) Using Debt Sensibly? finance.yahoo.com - June 25 at 8:11 PM
	Operational Highlights and Financial Results for the Period Ended March 31, 2021 finance.yahoo.com - June 2 at 9:06 PM
	Mesoblast Corporate Update and Financial Results Webcast markets.businessinsider.com - June 2 at 6:27 PM
	Improved Outcomes in Inflammatory Lung Disease With Remestemcel-L Published in Respiratory Research Journal finance.yahoo.com - May 25 at 7:19 AM
	Strength Seen in Mesoblast Limited (MESO): Can Its 6.1% Jump Turn into More Strength? finance.yahoo.com - May 3 at 2:01 PM
	Mesoblast Shares Rise As Remestemcel-L Cuts Mortality In Patients Below 65 Years With COVID-19 Related Respiratory Distress feeds.benzinga.com - April 30 at 10:27 AM
	Mesoblast Operational Highlights and Upcoming Milestones finance.yahoo.com - March 30 at 9:52 PM
	Philip J. Facchina, Chief Strategy Officer and Principal of SurgCenter Development, Joins Mesoblast Board finance.yahoo.com - March 29 at 9:24 AM
	Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Disease finance.yahoo.com - February 10 at 7:34 PM
	Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2020 finance.yahoo.com - January 28 at 7:18 PM
	Why Mesoblast Stock Skyrocketed Today finance.yahoo.com - January 11 at 5:07 PM
	Single Dose of Rexlemestrocel-L Provides Substantial and Durable Reduction in Heart Attacks, Strokes and Cardiac Death in Patients With Chronic Heart Failure finance.yahoo.com - January 11 at 2:05 AM
	Why Mesoblast Stock Plummeted on Friday finance.yahoo.com - December 18 at 6:50 PM
	Mesoblast Webcast – Update on COVID-19 ARDS Trial finance.yahoo.com - December 17 at 10:35 PM
	Why Mesoblast Stock Is Tanking Today finance.yahoo.com - December 15 at 1:27 PM
	Lawsuit for Investors in shares of Mesoblast Limited (OTC: MEOBF) announced by Shareholders Foundation finance.yahoo.com - December 8 at 9:03 AM
	FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com - December 7 at 2:28 AM
	MESO FINAL MONDAY DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mesoblast Limited Investors Seek Counsel Before Important December 7 Deadline in Securities Class Action – MESO finance.yahoo.com - December 6 at 4:27 PM
	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MESO, LOOP and TILE finance.yahoo.com - November 30 at 4:26 PM
	Analysts Just Made A Stunning Upgrade To Their Mesoblast Limited (ASX:MSB) Forecasts finance.yahoo.com - November 26 at 3:51 PM
	CLASS ACTION UPDATE for MESO, LOOP and BIIB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders finance.yahoo.com - November 25 at 12:40 PM
	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Royal Caribbean, Mesoblast, Loop Industries, and Turquoise Hill Resources and Encourages Investors to Contact the Firm finance.yahoo.com - November 24 at 4:37 PM
	SHAREHOLDER ALERT: MESO FAF LRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines finance.yahoo.com - November 24 at 6:35 AM
	LAWSUITS FILED AGAINST NXTC, MESO and LVS - Jakubowitz Law Pursues Shareholders Claims finance.yahoo.com - November 18 at 6:18 PM
	MESO LOSS ALERT: LONGSTANDING AND LEADING ROSEN LAW FIRM, Encourages Mesoblast Limited Investors With Large Losses Contact Firm before Important Deadline in Securities Class Action - MESO finance.yahoo.com - November 13 at 1:59 PM
	Rosen, National Trial Counsel, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action - MESO finance.yahoo.com - November 11 at 5:35 PM
	LAWSUITS FILED AGAINST GOCO, MESO and ZSAN - Jakubowitz Law Pursues Shareholders Claims finance.yahoo.com - November 11 at 12:34 PM
	Second Interim Analysis of Clinical Outcomes After 135 Patients Results in Recommendation to Continue Remestemcel-L Phase 3 Trial in COVID-19 ARDS finance.yahoo.com - November 11 at 7:34 AM
	Lawsuits Filed Against GLNG, RCL and MESO - Jakubowitz Law Pursues Shareholders Claims finance.yahoo.com - November 10 at 5:29 PM
	DEADLINE ALERT for RCL, MESO, LOOP, TRQ: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders finance.yahoo.com - November 10 at 12:28 PM
	SHAREHOLDER ALERT: C RCL MESO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines finance.yahoo.com - November 10 at 7:28 AM
	Rosen, Top Ranked Investor Counsel, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action - MESO finance.yahoo.com - November 6 at 7:23 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Law Suit and Upcoming Deadline – MESO finance.yahoo.com - November 4 at 10:13 PM

Get Mesoblast News Delivered to You Automatically

MEOBF Media Mentions By Week

MEOBF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MEOBF
News Sentiment
▼
-1.00

0.59
▲
Average
Medical
News Sentiment

MEOBF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MEOBF Articles
This Week
▼
1

0
▲
MEOBF Articles
Average Week

Get Mesoblast News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (OTCMKTS:MEOBF) was last updated on 8/14/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Mesoblast (MEOBF) News Today

MEOBF Media Mentions By Week

MEOBF Media Sentiment

MEOBF News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info